MediPaCe joins public involvement pledge to improve health research.
Find Out More
MediPaCe joins public involvement pledge to improve health research.
Find out more

Celebrating a Year of Positive Impact: A Review of 2024 in Patient-Centric Healthcare

As we approach the end of 2024, it is a perfect time to reflect on the significant advancements and impactful projects that have shaped the healthcare landscape, particularly in the realm of patient-centric care.

Award-Winning Patient Experience Solutions

We are honoured to have been recognized as the top patient experience solution provider in Europe in the 2024 Med Tech and Pharma Tech awards. This accolade is a testament to our innovative, values-driven approach and the tangible impact we have made in improving patient outcomes.

IHI Project Comfort: Revolutionizing Blood Sample Collection

One of the highlights of the year is the initiation of the IHI Project Comfort, where MediPaCe serves as the scientific coordinator. This large public-private partnership involves over 50 organizations working together to co-create and test the logistics, infrastructure, and tools necessary to make patient-centric blood microsampling a core healthcare tool. This project aims to establish microsampling as an acceptable alternative to traditional venous blood draws across Europe, enhancing accessibility and equity in healthcare, and supporting the decentralisation of clinical trials and care pathways.

The International Global Epilepsy Needs Study (GENS)

MediPace has been working with the International Bureau of Epilepsy throughout 2024 in designing and delivering this significant international effort to understand the non-medical, psychosocial, and everyday needs of people affected by epilepsy across their lives.


GENS has already reached some important milestones. The survey phase gathered an impressive 5,303 responses, providing valuable insights into lived experiences across 15 countries. This has currently being followed by 76 semi-structured interviews, offering a deeper understanding of individual challenges and priorities. Focus groups will then explore the specific needs of six underrepresented subgroups, identified through the survey and interview
findings.

Collaboration has been central to the study, with MediPaCe and IBE partnering with 19 patient organisations for navigating ethics approvals, translations, and study recruitment. Through GENS, we aim to amplify the voices of patients and caregivers, ensuring their needs guide meaningful action and change.

Patient Involvement and Collaboration

A major milestone this year was the launch of PiCC United (Patient Involvement and Collaboration Community United). After two years of co-creation, PiCC United addresses long-standing challenges in patient engagement, such as lack of diversity, representation, and efficient engagement in under-served rare diseases. This collaborative solution-oriented approach simplifies patient engagement, boosts diversity, and provides support and community for patients, bridging the gap between healthcare, life science organizations, and patients themselves.

Supporting Non-Profit Communities

We have also collaborated with non-profit communities to develop tools that enhance patient involvement and patient-centric healthcare. For instance, the ‘Patient Survey’ co-created with the Patient-Centric Sampling Interest Group (PCSIG) helps organizations gather patient insights consistently, ensuring that solutions are patient-centered from the outset even if the organisation developing the approach has minimal funds or time.

Shared Commitment to Public Involvement in Research

MediPaCe is proud to have joined the Shared Commitment to Public Involvement in Research, a movement coordinated by The Health Research Authority and the National Institute for Health and Care Research. This network aims to drive up standards in health and social care research across the UK.

Research and Publications

Our commitment to patient research and evidence generation has led to significant contributions, including a study on patient experiences during breast cancer radiotherapy published in the BMJ. This study has been picked up by mainstream media and is supporting a Health Technology Assessment (HTA) submission, further driving access to improvements in patient care.

Staff Growth and Educational Achievements

This year has also seen the addition of new staff members, including Pepa as a senior program manager and Molly, who joined our administration office after completing her PhD in neurodegeneration. Additionally, two MSc qualifications within psychology have strengthened our integrated health psychology and behaviour change capabilities.

Conclusion

As we close out 2024, we reflect on a year marked by innovation, collaboration, and a deep commitment to patient-centric care. We are grateful for the support of our partners, patients, and the broader healthcare community. Here’s to an even more successful and impactful 2025! We wish you a wonderful holiday season.